Literature DB >> 19723538

A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link?

Adolfo E Cuadra1, Zhiying Shan, Colin Sumners, Mohan K Raizada.   

Abstract

The renin-angiotensin system (RAS) plays a central role in the brain to regulate blood pressure (BP). This role includes the modulation of sympathetic nerve activity (SNA) that regulates vascular tone; the regulation of secretion of neurohormones that have a critical role in electrolyte as well as fluid homeostasis; and by influencing behavioral processes to increase salt and water intake. Based on decades of research it is clear that angiotensin II (Ang II), the major bioactive product of the RAS, mediates these actions largely via its Ang II type 1 receptor (AT1R), located within hypothalamic and brainstem control centers. However, the mechanisms of brain RAS function have been questioned, due in large part to low expression levels of the rate limiting enzyme renin within the central nervous system. Tissue localized RAS has been observed in heart, kidney tubules and vascular cells. Studies have also given rise to the hypothesis for localized RAS function within the brain, so that Ang II can act in a paracrine manner to influence neuronal activity. The recently discovered (pro)renin receptor (PRR) may be key in this mechanism as it serves to sequester renin and prorenin for localized RAS activity. Thus, the PRR can potentially mitigate the low levels of renin expression in the brain to propagate Ang II action. In this review we examine the regulation, expression and functional properties of the various RAS components in the brain with particular focus on the different roles that PRR may have in BP regulation and hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19723538      PMCID: PMC2815255          DOI: 10.1016/j.pharmthera.2009.07.007

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  182 in total

Review 1.  Signaling by distinct classes of phosphoinositide 3-kinases.

Authors:  B Vanhaesebroeck; M D Waterfield
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

Review 2.  Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata.

Authors:  D B Averill; D I Diz
Journal:  Brain Res Bull       Date:  2000-01-15       Impact factor: 4.077

Review 3.  The physiological role of AT1 receptors in the ventrolateral medulla.

Authors:  T Tagawa; M A Fontes; P D Potts; A M Allen; R A Dampney
Journal:  Braz J Med Biol Res       Date:  2000-06       Impact factor: 2.590

4.  Gbetagamma dimers stimulate vascular L-type Ca2+ channels via phosphoinositide 3-kinase.

Authors:  P Viard; T Exner; U Maier; J Mironneau; B Nürnberg; N Macrez
Journal:  FASEB J       Date:  1999-04       Impact factor: 5.191

5.  Activation of the brain angiotensin system by in vivo human angiotensin-converting enzyme gene transfer in rats.

Authors:  S Nakamura; A Moriguchi; R Morishita; K Yamada; T Nishii; N Tomita; M Ohishi; Y Kaneda; J Higaki; T Ogihara
Journal:  Hypertension       Date:  1999-08       Impact factor: 10.190

6.  Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen.

Authors:  M Schinke; O Baltatu; M Böhm; J Peters; W Rascher; G Bricca; A Lippoldt; D Ganten; M Bader
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

7.  Sympathoinhibition after angiotensin receptor blockade in the rostral ventrolateral medulla is independent of glutamate and gamma-aminobutyric acid receptors.

Authors:  T Tagawa; J Horiuchi; P D Potts; R A Dampney
Journal:  J Auton Nerv Syst       Date:  1999-07-07

8.  Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells.

Authors:  M Ushio-Fukai; R W Alexander; M Akers; Q Yin; Y Fujio; K Walsh; K K Griendling
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

9.  Role of phosphatidylinositol 3-kinase in angiotensin II regulation of norepinephrine neuromodulation in brain neurons of the spontaneously hypertensive rat.

Authors:  H Yang; M K Raizada
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

10.  Angiotensinogen gene-activating elements regulate blood pressure in the brain.

Authors:  T Nishii; A Moriguchi; R Morishita; K Yamada; S Nakamura; N Tomita; Y Kaneda; A Fukamizu; H Mikami; J Higaki; T Ogihara
Journal:  Circ Res       Date:  1999-08-06       Impact factor: 17.367

View more
  38 in total

Review 1.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

Review 2.  The central nervous system and inflammation in hypertension.

Authors:  Paul J Marvar; Heinrich Lob; Antony Vinh; Faresa Zarreen; David G Harrison
Journal:  Curr Opin Pharmacol       Date:  2010-12-31       Impact factor: 5.547

3.  Multiscale model of dynamic neuromodulation integrating neuropeptide-induced signaling pathway activity with membrane electrophysiology.

Authors:  Hirenkumar K Makadia; Warren D Anderson; Dirk Fey; Thomas Sauter; James S Schwaber; Rajanikanth Vadigepalli
Journal:  Biophys J       Date:  2015-01-06       Impact factor: 4.033

Review 4.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

Review 5.  The renin angiotensin system and the metabolic syndrome.

Authors:  Annette D de Kloet; Eric G Krause; Stephen C Woods
Journal:  Physiol Behav       Date:  2010-04-08

6.  Is (pro)renin receptor a multifunctional receptor?

Authors:  Qiuhong Li; Mohan K Raizada
Journal:  Hypertension       Date:  2010-04-05       Impact factor: 10.190

7.  Involvement of the brain (pro)renin receptor in cardiovascular homeostasis.

Authors:  Zhiying Shan; Peng Shi; Adolfo E Cuadra; Ying Dong; Gwyneth J Lamont; Qiuhong Li; Dale M Seth; L Gabriel Navar; Michael J Katovich; Colin Sumners; Mohan K Raizada
Journal:  Circ Res       Date:  2010-08-05       Impact factor: 17.367

Review 8.  The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications.

Authors:  Amanda J Miller; Amy C Arnold
Journal:  Clin Auton Res       Date:  2018-11-09       Impact factor: 4.435

9.  Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Begoña Villar-Cheda; Rita Valenzuela; Maria J Guerra
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 10.  Neuroimmune communication in hypertension and obesity: a new therapeutic angle?

Authors:  Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.